News and Events NovaBiotics Pharma Division Highlighted in Healthcare UK report Nov 20, 2024 NovaBiotics announces move to ONE BioHub Nov 5, 2024 NovaBiotics Consumer Health Signs Global Sales and Distribution Agreement for its Breakthrough Nail Health Solution, Tinexyl®. Oct 8, 2024 TinexylPRO Launched at Key Industry Events May 27, 2024 Appointment of Dr Trevor Phillips to the Board of NovaBiotics Sep 6, 2023 Publication of NovaBiotics’ peer reviewed research on cysteamine’s antiviral and anti-inflammatory mechanisms Aug 16, 2023 Additional International Organization for Standardisation (ISO) accreditations for NovaBiotics Jan 23, 2023 NovaBiotics Announces Presentations of New Data for NM002 and NP339 at the European Congress of Clinical Microbiology & Infectious Diseases Apr 21, 2022 NovaBiotics to Present at the H.C. Wainwright BioConnect Conference Jan 4, 2022 NovaBiotics Announces First Patient Enrolment into the Cysteamine Domain of REMAP-CAP Dec 8, 2021 « Older Entries Categories Press Releases Events In the news Archives 2021 2020 2019
NovaBiotics Consumer Health Signs Global Sales and Distribution Agreement for its Breakthrough Nail Health Solution, Tinexyl®. Oct 8, 2024
Publication of NovaBiotics’ peer reviewed research on cysteamine’s antiviral and anti-inflammatory mechanisms Aug 16, 2023
Additional International Organization for Standardisation (ISO) accreditations for NovaBiotics Jan 23, 2023
NovaBiotics Announces Presentations of New Data for NM002 and NP339 at the European Congress of Clinical Microbiology & Infectious Diseases Apr 21, 2022
